Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Immusoft
3215
Immusoft
Technology
Biotechnology
Health Care
Medical
Therapeutics
Immusofts mission is to develop a completely new platform for delivering medicines programming a patients own cells to become miniature drug factories.
Suggest edits
Type
B2c
Founded
2009
Raised
$30.2M
Follow us
Also headquartered in Seattle
Amazon
GeekWire
Starbucks
Amazon Web Services
Zillow
Redfin
Tableau
Gates Foundation
Bittrex
Bungie
Companies in the same industry
Trobix Bio
Vortech Biosystems
Gadeta
Atterx Biotherapeutics
NeuroTherapia, Inc.
Motus Therapeutics
CureVac AG
Nohla Therapeutics
Therachon AG
Lysosomal Therapeutics
Alexa global traffic share
Twitter followers
Overview
Funding
4
Acquisitions
1
People
Add info
Latest funding
Show all
$4,500,000
Venture capital - 2020
Mesa Verde Venture Partners
Breakout Ventures
Ikarian Capital
$20,000,000
Venture capital (Series B) - 2019
DEFTA Partners
Mesa Verde Venture Partners
Breakout Ventures
+2
Team Size
10+
Employees
I work here
Location
Seattle
,
United States
Headquarters
Explore Seattle
$4,500,000
Venture capital
GeekWire
Seattle gene therapy biotech startup Immusoft raises $4.5M
Xconomy
Seattle Startup Funding News: Immusoft, TurboPatent, VYRTY & More
$20,000,000
Venture capital (Series B)
FinSMEs
,
PE HUB
,
GeekWire
, +1
Immusoft Raises $20M in Series B Financing
$3,000,000
Venture capital (Series B)
GeekWire
Gene therapy startup Immusoft raises $3M, appoints new CEO as it approaches clinical trials
Science
Health
Strategy
$2,700,000
Venture capital (Series A)
Immusoft Corporation
,
Immusoft Corporation
http://immusoft.com/wp-content/uploads/2016/11/Immusoft-Closes-Round-Nov-2016.pdf
Acquisition
GeekWire
Gene therapy biotech startup Immusoft acquires Discovery Genomics
Science
Health
